Overview
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Status:
Completed
Completed
Trial end date:
2008-12-01
2008-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this trial is to understand if adding saxagliptin to metformin therapy is safe and works better than taking either saxagliptin or metformin alonePhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AstraZenecaTreatments:
MetforminPioglitazone
Saxagliptin
Criteria
Inclusion Criteria:- Type 2 diabetes
- Inadequate blood sugar control
- No current treatment with other medications to lower blood sugar
Exclusion Criteria:
- Major heart, liver or kidney problems
- Pregnant or breast feeding